SUPRO Adhesion Barrier Gel

Post-surgical adhesions can cause serious complications such as:

- Bowel obstruction, female infertility, and post-surgical pain. 

- The intestines and gall bladder may be damaged and other diseases may occur when a   

    second operation is performed. 

- Patients experiencing serious discomfort during their lifetime.

SUPRO Gel is used to reduce or prevent post-surgical adhesions. It can be used after general surgery, gynaecological pelvic surgery, Orthopedics and spinal surgery.

It perfectly adheres to the tissue surface and to the organ reducing direct contact between the two surfaces by creating a physical barrier at the same time inhibit bleeding and oozing.

It stimulates tissue repair reducing the injury time and inhibits inflammatory granulocyte action reducing tissue damage and the adhesion effects released by damaged tissues.

Restrictions:

-  No studies have been conducted and evaluated regarding the use of SUPRO GEL during 

    pregnancy, in nursing mothers and children. The use of the product is not recommended 

    in these conditions.

-  No studies have been conducted in women who have become pregnant within the first 

    month after use of SUPRO Gel. Therefore patients should be advised to avoid conception 

    during the first menstrual cycle after the application of SUPRO Gel.

-  Use of SUPRO Gel with other adhesion barriers has not been clinically evaluated.

-  SUPRO Gel is not a haemostatic agent. Any active bleeding on site should be stopped prior 

    to use of SUPRO Gel.

- SUPRO Gel has no bacteriostatic or bactericidal activity. In case of existence of 

    infections, treatment should be admitted prior to use of SUPRO Gel.

- SUPRO Gel is not a dural sealant. Any dural defects should be repaired prior to use 

    of SUPRO Gel.

To access the Instruction for Use (IFU) pdf document click the button labelled SUPRO IFU Datasheet.

Do not use SUPRO Gel on patients who have malignant tumours or active infections in the body. Assessment of risk should be made by the physician to decide whether or not to use the product.

Do not apply in patients with known sensitivity/ allergy to SUPRO Gel or products containing sodium hyaluronate or who have anaphylactic shock history.

Do not inject intravenously and intravascularly.

Do not use in the treatment of acute and chronic pyogenic arthritis, synovium and joint tuberculosis, haemorrhagic diseases, and haemophilia patients.

Adverse Events

The following adverse events have been reported in the post market phase following the use of other existing gels that are intended for adhesion barrier: infection, pain, fever, swelling, inflammation, foreign body reaction, sensation, poor performance, fistula, leak, peritonitis, sepsis, muscle pulling and abdomino-pelvic abscess.

Precautions

The quantity of SUPRO Gel used depends on the extent of wounds in the surgical area. It is not recommended to use SUPRO Gel over a dose of 2 ml/kg of body weight unless at the discretion of the physician.

The Patient should be tested for possible existing allergy/sensitivity before surgery.

Avoid using disinfectants containing quaternary ammonium salts for skin preparation simultaneously because sodium hyaluronate can precipitate in the presence of salts.

To access the Instruction for Use (IFU) pdf document click the button labelled SUPRO IFU Datasheet.